Figure 1: Basic Component of Transdermal Patch
Sno |
drug |
Marketed formulation |
Application duration |
Typeof formulation |
dose |
referances |
1 |
Donepezil |
Adlarity® |
7 days |
Sustain release |
5 or 10mg/day |
[5-7] |
2 |
rivastigmine |
Exelon® |
24 hrs |
sustained release |
9.5 mg/day |
[1,8,9] |
Table 1: A summary of transdermal patches/products and their unique features
Sr, no. |
component |
Functions |
1 |
Baking |
The backing protects the patch from external contamination |
2 |
drug reservoir |
The drug reservoir containing the medicine |
3 |
Membrane |
The membrane regulates medication release from the reservoir via the multi-layers and intothe skin. |
4 |
Adhesive |
The patch components are adhered to the skin using adhesive. |
5 |
Liner |
The liner protects the patch during storage. |
Table 2: Basic Component of Transdermal Patch
Sr. |
Types of transdermalpatches: |
Component |
Examples |
Referances |
1 |
Drug-in-Adhesive System |
Backing,Adhesive+ drug,liner. |
Rivastigmine drug-in-adhesive patch |
[10] |
2 |
Reservoir System |
Backing,Drug,membrane,adhesive,liner. |
Galantamine hydrobromide loaded gel drug reservoirs in transdermal patch |
[11] |
3 |
Matrix System |
backing,drugin adhesive,liner. |
Rivastigmine matrix-type transdermal patch |
[12] |
4 |
Micro-Reservoir System: |
backing,drug+ polymer,adhesive,liner. |
Galantamine Gel as Drug Reservoir in Transdermal Patch |
[13] |
Table 3: Types of transdermal patch
MN type |
Characteristics |
Materialdelivary rate |
Application |
Advantages |
Disadvantage |
Multi/singleuse |
Solid |
The skin forms channels that let drugs penetrate to the bottom layer of skin..Mechanical strength is adequate.Sharper point.Simple architecture |
Silicon Metal Polymer, fast rate |
Drug delivery Cosmetic |
It can be fabricated |
Patch is susceptible to infection |
Can be reuse |
Hollow |
An empty form that will be filled with the medication.Controlling drug release over time.Simple architecture |
Silicon, fast rate |
Disease diagnosis |
Large amount of drug can be incorporated |
Here needle design, insertion method can lead in problems like leakage, clogging. |
Can be reuse |
Coated |
Because of the design, it carries less of the drug.The ability to distribute proteins and DNA with little invasiveness.Intricate structure |
Silicon, fast rate |
Drug delivery Vaccine delivery |
It enables quick delivery to skin |
Patch is susceptible to infection |
Single purpose |
Dissolving |
Allows for the fast release of macromolecules.Structure that iscomplex |
Polymer, slow rate |
Drug delivery Cosmetic Vaccine delivery |
Administered easily in one set application |
It requires expertise skills during manufacturing and take time to dissolve. |
Single use |
Table 4: Types of micro needles [39]
Drug |
Carrier Materia |
Particle Size(nm |
Zeta Potential(mV) |
Outcome |
Donepezil |
Stearic acid, oleic acid, lecithin,sodium taurodeoxytaurocholate |
177.05± |
−55.35 |
in vitro: Increased drug skin permeation.Enhanced drug delivery |
Rivastigmine |
GMS, castor oil |
134.5 |
−11.8 ±2.24 |
in vitro/in vivo: Non- irritant. |
Table 5: Nanoparticle-based drug delivery systems to treat AD (transdermal) [40]
Figure 1: Basic Component of Transdermal Patch
Figure 2: Microneedle-Based Patch
Tables at a glance
Figures at a glance